MTOR and breast cancer: Amentoflavone inhibits TNFα-induced Gli1 activation in breast tumor cells, resulting in reduced invasiveness of human breast cancer cells by interceding AKT/mTOR/S6K1 signaling and blocking the migration and invasiveness of MDA-MB-231 cells (Qiu et al., 2021).